Tonix Pharm Hld (TNXP) |
|
1.13 -0.07 (-5.83%)
|
08-07 15:00 |
|
Open: |
1.18 |
Pre. Close: |
1.2 |
|
High:
|
1.19 |
Low:
|
1.12 |
|
Volume:
|
10,445,894 |
Market Cap:
|
142M |
|
|
|
|
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, licensing, acquiring, and developing drugs and biologics to treat and prevent human disease and alleviate suffering in the United States. It is developing TNX-102 SL, a tablet containing cyclobenzaprine that is Phase III clinical trial for the treatment of fibromyalgia; and that is in Phase III clinical trial for the treatment of posttraumatic stress disorder, as well as TNX-102 SL for the treatment of agitation in Alzheimer's disease and alcohol use disorder. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.374 - 1.381 |
1.381 - 1.388 |
|
Low:
|
1.179 - 1.189 |
1.189 - 1.196 |
|
Close:
|
1.186 - 1.2 |
1.2 - 1.212 |
|
Technical analysis |
as of: 2020-08-07 2:31:00 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 2.01 One year: 2.87 |
| Support: |
Support1: 0.52 Support2: 0.43 |
| Resistance: |
Resistance1: 1.72 Resistance2: 2.46 |
| Pivot: |
1.32  |
| Moving Average: |
MA(5): 1.21  MA(20): 1.14
MA(100): 0.78 MA(250): 1.79 |
| MACD: |
MACD(12,26): 0.12 Signal(9): 0.15 |
| Stochastic oscillator: |
%K(14,3): 24.34 %D(3): 31.21 |
| RSI: |
RSI(14): 52.98 |
| 52-week: |
High: 5.90 Low: 0.39 Change(%): -74.7 |
| Average Vol(K): |
3-Month: 2561393 10-Days: 1718648 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.TNXP has closed above bottom band by 21.2%. Bollinger Bands are 54.6% wider than normal. The large width of the bands suggest high volatility as compared to TNXP's normal range. The bands have been in this wide range for 14 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 06 Aug 2020
New Insight on Tonix Pharmaceuticals Holding Corp. (TNXP) - Stocks Register
Thu, 06 Aug 2020
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) 17.76% up over a week, Can The Stock Hit well above $1.52? - Marketing Sentinel
Thu, 06 Aug 2020
What Tonix Pharmaceuticals Holding Corp. (TNXP) Doesn’t Want You to Know - The News Heater
Thu, 30 Jul 2020
A Look At The Behavior Of Tonix Pharmaceuticals Holding Corp. (TNXP) Stock - Stocks Register
Thu, 30 Jul 2020
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Stock is Plummeting, Here is Why - The Oracle Dispatch
Thu, 30 Jul 2020
Tonix Pharmaceuticals to Participate in SNN Network Virtual Investor Conference - GlobeNewswire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Global Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
126 |
| Shares Float (M) |
52 |
|
% Held by Insiders
|
0.05 |
|
% Held by Institutions
|
7.00 |
|
Shares Short (K)
|
1,510 |
|
Shares Short P. Month (K)
|
514 |
Stock Financials |
|
EPS
|
-4.516 |
|
EPS Est This Year
|
-3.020 |
|
EPS Est Next Year
|
-2.470 |
|
Book Value (p.s.)
|
0.630 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-69.1 |
|
Return on Equity (ttm)
|
-120.9 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.237 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-27 |
|
Levered Free Cash Flow (M)
|
-16 |
Stock Valuations |
|
PE Ratio
|
-0.25 |
|
PEG Ratio
|
|
|
Price to Book value
|
1.81 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-5.24 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
